{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:19:38Z","timestamp":1790363978768,"version":"4.1.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cardfail.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:18:57Z","timestamp":1783178337000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Heart Failure Pharmacotherapy Across the Transcatheter Aortic Valve Replacement Continuum"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-4458","authenticated-orcid":false,"given":"TAKAYUKI","family":"ONISHI","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GILBERT H.L.","family":"TANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANDY","family":"MOYAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1666-447X","authenticated-orcid":false,"given":"KRISHNA SANTOSH","family":"VEMURI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5204-5372","authenticated-orcid":false,"given":"SRI","family":"SWAMINATHAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JOHANNA","family":"CONTRERAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-3477","authenticated-orcid":false,"given":"NOAH","family":"MOSS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SAHIL","family":"KHERA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5659-5873","authenticated-orcid":false,"given":"AMIT","family":"HOODA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GEORGE","family":"DANGAS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ANNAPOORNA S.","family":"KINI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SAMIN K.","family":"SHARMA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SUNNY","family":"GOEL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cardfail.2026.06.011_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3390\/jcm13020373","article-title":"Transcatheter aortic valve replacement: current status and future indications","volume":"13","author":"Vinayak","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012195","article-title":"Rehospitalization events after aortic valve replacement: insights from the PARTNER trial","volume":"15","author":"Huded","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0003","first-page":"413","article-title":"The relationship between heart-failure hospitalization and mortality in patients receiving transcatheter aortic valve replacement","volume":"35","author":"Nazzari","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0004","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.jchf.2023.07.003","article-title":"Aortic valve disease, transcatheter aortic valve replacement, and the heart failure patient: a state-of-the-art review","volume":"11","author":"Okumus","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jtcvs.2011.04.044","article-title":"Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications","volume":"143","author":"Yarbrough","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0006","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.jcmg.2020.07.007","article-title":"Diffuse myocardial fibrosis and diastolic function in aortic stenosis","volume":"13","author":"Lee","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0007","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11886-016-0753-6","article-title":"Aortic stenosis, a left ventricular disease: insights from advanced imaging","volume":"18","author":"Badiani","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0008","doi-asserted-by":"crossref","first-page":"4970","DOI":"10.7150\/thno.104899","article-title":"KMV-mediated cardiomyocyte-to-endothelial cell signaling drives capillary rarefaction to promote heart failure following pressure overload","volume":"15","author":"Gao","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0009","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCRESAHA.114.300507","article-title":"Angiogenesis and cardiac hypertrophy: maintenance of cardiac function and causative roles in heart failure","volume":"114","author":"Oka","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.acvd.2025.11.004","article-title":"Cardiac remodelling in aortic stenosis","volume":"119","author":"Clavel","year":"2026","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0011","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1161\/HYPERTENSIONAHA.118.11065","article-title":"Role of renin-angiotensin-aldosterone system activation in promoting cardiovascular fibrosis and stiffness","volume":"72","author":"Jia","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0012","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcmg.2018.11.026","article-title":"Imaging and impact of myocardial fibrosis in aortic stenosis","volume":"12","author":"Bing","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0013","doi-asserted-by":"crossref","first-page":"983.e7","DOI":"10.1016\/j.crad.2018.07.095","article-title":"Prognostic value of late gadolinium enhancement on CMR in patients with severe aortic valve disease: a systematic review and meta-analysis","volume":"73","author":"Chen","year":"2018","journal-title":"Clin Radiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0014","article-title":"Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: a systematic review and meta-analysis","volume":"17","author":"Zhang","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0015","first-page":"162","article-title":"Acute invasive hemodynamic effects of transcatheter aortic valve replacement","volume":"25","author":"Chrissoheris","year":"2016","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0016","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.3390\/jcm13133777","article-title":"Reducing left ventricular wall stress through aortic valve enlargement via transcatheter aortic valve implantation in severe aortic stenosis","volume":"13","author":"Chiang","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0017","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jcmg.2019.02.034","article-title":"Multimodality imaging markers of adverse myocardial remodeling in aortic stenosis","volume":"12","author":"Treibel","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0018","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1016\/j.jacc.2020.10.032","article-title":"Diastolic function and clinical outcomes after transcatheter aortic valve replacement: PARTNER 2 SAPIEN 3 registry","volume":"76","author":"Ong","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0019","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00004872-199816090-00016","article-title":"Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition","volume":"16","author":"Grimm","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0020","first-page":"459","article-title":"The effects of enalapril on p53 expression in left ventricular cardiomyocytes after aortic stenosis","volume":"20","author":"Ziori","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0021","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1001\/archinte.165.8.858","article-title":"Angiotensin-converting enzyme inhibitors and change in aortic valve calcium","volume":"165","author":"O'Brien","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0022","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(05)60717-9","article-title":"Aortic stenosis and ACE inhibitors","volume":"352","author":"Rimington","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0023","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehz769","article-title":"Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries","volume":"41","author":"Chen","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1234368","article-title":"Renin-angiotensin system inhibitors reduce cardiovascular mortality in hypertensive patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: insights from the EffecTAVI registry","volume":"10","author":"Basile","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2022.12.012","article-title":"Association of ACEI\/ARB and statin prescribing patterns with mortality after transcatheter aortic valve replacement (TAVR): findings from real-world claims data","volume":"258","author":"Cubeddu","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.100927","article-title":"Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers after transcatheter aortic valve replacement: a meta-analysis","volume":"3","author":"Bhat","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0027","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/ehjcvp\/pvac027","article-title":"Effects of renin-angiotensin system inhibitor type and dosage on survival after transcatheter aortic valve implantation","volume":"8","author":"Fischer-Rasokat","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0028","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jcin.2024.02.011","article-title":"Long-term impact of cardiac damage following transcatheter aortic valve replacement","volume":"17","author":"Nakase","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0029","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0030","doi-asserted-by":"crossref","first-page":"C1150","DOI":"10.1152\/ajpcell.00569.2025","article-title":"Vascular effects of SGLT2 inhibitors: evidence and mechanisms","volume":"329","author":"Goes-Santos","year":"2025","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0031","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacbts.2024.02.012","article-title":"Human aortic stenotic valve-derived extracellular vesicles induce endothelial dysfunction and thrombogenicity through AT1R\/NADPH oxidases\/SGLT2 pro-oxidant pathway","volume":"9","author":"Hmadeh","year":"2024","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0032","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jchf.2021.04.014","article-title":"Mechanistic insights of empagliflozin in nondiabetic patients with HFrEF: from the EMPA-TROPISM study","volume":"9","author":"Requena-Ibanez","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0033","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-026-06682-w","article-title":"Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial","volume":"69","author":"Yan","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0034","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s40001-025-02834-7","article-title":"Impact of SGLT2 inhibitors on myocardial fibrosis in diabetic HFpEF: a longitudinal study","volume":"30","author":"Albulushi","year":"2025","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0035","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.3390\/jcm15114061","article-title":"Effect of dapagliflozin on myocardial fibrosis after STEMI: a double-blind, placebo-controlled randomized trial","volume":"15","author":"Ortega-Paz","year":"2026","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0036","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ejhf.3145","article-title":"Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: the BIO-AS study","volume":"26","author":"Scisciola","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0037","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12933-025-02773-x","article-title":"Impact of SGLT2-inhibitors on acute kidney injury in diabetic patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI)","volume":"24","author":"Paolisso","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0038","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011521","article-title":"Myocardial effects of aldosterone antagonism in heart failure with preserved ejection fraction","volume":"9","author":"McDiarmid","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0039","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCULATIONAHA.123.067620","article-title":"Mineralocorticoid receptor antagonism prevents aortic plaque progression and reduces left ventricular mass and fibrosis in patients with type 2 diabetes and chronic kidney disease: the MAGMA trial","volume":"150","author":"Rajagopalan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ahj.2019.02.005","article-title":"Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI trial","volume":"211","author":"Bulluck","year":"2019","journal-title":"Am Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0041","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0042","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ejhf.2726","article-title":"Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials","volume":"25","author":"Ferreira","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0043","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.shj.2025.100751","article-title":"Finerenone in patients undergoing TAVR for nonrheumatic aortic stenosis: insights from a real-world cohort","volume":"10","author":"Massad","year":"2026","journal-title":"Struct Heart"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0045","first-page":"1361","article-title":"The effect of periprocedural beta blocker withdrawal on arrhythmic risk following transcatheter aortic valve replacement","volume":"93","author":"Younis","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0046","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001269","article-title":"Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry","volume":"7","author":"Saito","year":"2020","journal-title":"Open Heart"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0047","first-page":"351","article-title":"Impact of early atrioventricular nodal blocker use post-transcatheter aortic valve replacement","volume":"107","author":"Edwards","year":"2026","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101428","article-title":"Causes and determinants of heart failure readmissions post transcutaneous aortic valve replacement: a systematic review and meta-analysis","volume":"48","author":"Yasmin","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0049","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcin.2025.10.050","article-title":"Clinical application of guideline-directed medical therapy in TAVR patients with heart failure and reduced ejection fraction","volume":"19","author":"Kobari","year":"2026","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0051","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.jcin.2020.03.011","article-title":"Left ventricular hypertrophy and clinical outcomes over 5 years after TAVR: an analysis of the PARTNER trials and registries","volume":"13","author":"Gonzales","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0052","doi-asserted-by":"crossref","unstructured":"Onishi T, Khera S, Ferrandez-Escarabajal M, Safi LM, Hooda A, Dangas GD, et al. Left ventricular remodeling after redo transcatheter aortic valve replacement: A first-in-human computed tomography analysis. J Cardiovasc Comput Tomogr. Published online May 14, 2026. https:\/\/doi.org\/10.1016\/j.jcct.2026.05.001.","DOI":"10.1016\/j.jcct.2026.05.001"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0053","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1016\/j.jacc.2013.02.087","article-title":"Comparison of transcatheter and surgical aortic valve replacement in severe aortic stenosis: a longitudinal study of echocardiography parameters in cohort A of the PARTNER trial (placement of aortic transcatheter valves)","volume":"61","author":"Hahn","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0054","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12968-020-00629-9","article-title":"Cardiac structural changes after transcatheter aortic valve replacement: systematic review and meta-analysis of cardiovascular magnetic resonance studies","volume":"22","author":"Mehdipoor","year":"2020","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0055","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1001\/jama.2018.18077","article-title":"Association of renin-angiotensin inhibitor treatment with mortality and heart failure readmission in patients with transcatheter aortic valve replacement","volume":"320","author":"Inohara","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0056","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ejhf.3151","article-title":"Transcatheter aortic valve replacement in heart failure","volume":"26","author":"Parikh","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0057","doi-asserted-by":"crossref","first-page":"E662","DOI":"10.25270\/jic\/20.00619","article-title":"Acute kidney injury and renin-angiotensin system inhibition following transcatheter aortic valve replacement","volume":"33","author":"Phuong","year":"2021","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0058","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/heartjnl-2017-311738","article-title":"Renin-angiotensin system blockade therapy after transcatheter aortic valve implantation","volume":"104","author":"Ochiai","year":"2018","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0059","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jacc.2019.05.055","article-title":"Renin-angiotensin system inhibition following transcatheter aortic valve replacement","volume":"74","author":"Rodriguez-Gabella","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0060","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjcard.2020.11.010","article-title":"Optimal medical therapy following transcatheter aortic valve implantation","volume":"141","author":"Kaewkes","year":"2021","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0061","first-page":"E88","article-title":"Impact of renin-angiotensin system inhibitors on outcomes after transcatheter aortic valve replacement: a meta-analysis","volume":"97","author":"Sun","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0062","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.035460","article-title":"Ramipril after transcatheter aortic valve implantation in patients without reduced ejection fraction: the RASTAVI randomized clinical trial","volume":"13","author":"Amat-Santos","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0063","first-page":"1554","article-title":"A Bayesian meta-analysis of renin-angiotensin system inhibitors following TAVR","volume":"107","author":"Oliveira","year":"2026","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0064","first-page":"443","article-title":"Dose-dependent effect of renin-angiotensin system blockade following transcatheter aortic valve replacement","volume":"37","author":"Ledwoch","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0065","first-page":"e35","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"143","author":"Otto","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0066","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s12933-024-02504-8","article-title":"SGLT2-inhibitors in diabetic patients with severe aortic stenosis and cardiac damage undergoing transcatheter aortic valve implantation (TAVI)","volume":"23","author":"Paolisso","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0067","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa2500366","article-title":"Dapagliflozin in patients undergoing transcatheter aortic-valve implantation","volume":"392","author":"Raposeiras-Roubin","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0068","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.3390\/jcm14197001","article-title":"Association of SGLT2 inhibitors with mortality and bioprosthesis valve failure after TAVR: a propensity-matched cohort study","volume":"14","author":"Morel","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0069","doi-asserted-by":"crossref","unstructured":"Jain H, Soni K, Jain J, Goyal A, Passey S, Goldsweig AM. Sodium-glucose cotransporter-2 inhibitors following transcatheter aortic valve replacement: a meta-analysis. Cardiol Rev. Published online December 16, 2025. https:\/\/doi.org\/10.1097\/CRD.0000000000001150.","DOI":"10.1097\/CRD.0000000000001150"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0070","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.3390\/jcm12113742","article-title":"Negative prognostic impact of mineralocorticoid receptor antagonist in elderly patients receiving TAVR","volume":"12","author":"Imamura","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0107","article-title":"Our experience with transcatheter aortic valve replacement medication outcomes from 2013 to 2016","volume":"11","author":"Herron","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0071","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jchf.2025.02.007","article-title":"Management of heart failure with improved ejection fraction: current evidence and controversies","volume":"13","author":"Kodur","year":"2025","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0072","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0073","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-095105","article-title":"Evaluation of the efficacy of angiotensin receptor-neprilysin inhibitor in patients with aortic stenosis undergoing transcatheter aortic valve implantation: protocol for a randomised, open-label, controlled study","volume":"15","author":"Kitahara","year":"2025","journal-title":"BMJ Open"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0074","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.amjcard.2026.02.043","article-title":"Association of GLP-1 receptor agonist and SGLT2 inhibitor with cardiovascular outcomes after transcatheter aortic valve replacement","volume":"266","author":"Fahoury","year":"2026","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0075","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.jacc.2024.08.021","article-title":"Effect of semaglutide on cardiac structure and function in patients with obesity-related heart failure","volume":"84","author":"Solomon","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0076","doi-asserted-by":"crossref","unstructured":"Goyal A, Saeed H, Jain H, Hurjkaliani S, Mahalwar G, Jaiswal V, et al. Cardiovascular outcomes with GLP-1 receptor agonists in patients with diabetes or obesity undergoing transcatheter aortic valve replacement. Can J Cardiol. Published online April 20, 2026. https:\/\/doi.org\/10.1016\/j.cjca.2026.04.003.","DOI":"10.1016\/j.cjca.2026.04.003"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0077","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2023.09.831","article-title":"Antithrombotic therapy for patients undergoing cardiac electrophysiological and interventional procedures: JACC state-of-the-art review","volume":"83","author":"Di Biase","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0078","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/eurheartj\/ehab196","volume":"42","author":"Ten Berg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0079","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0080","doi-asserted-by":"crossref","first-page":"7632","DOI":"10.3390\/jcm12247632","article-title":"Antithrombotic management for transcatheter aortic valve implantation","volume":"12","author":"Ya'Qoub","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0081","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2023.05.061","article-title":"ACC\/AHA and ESC\/EACTS guidelines for the management of valvular heart diseases: JACC guideline comparison","volume":"82","author":"Coisne","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0082","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcin.2012.03.012","article-title":"Pathology of transcatheter valve therapy","volume":"5","author":"Nietlispach","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0083","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005066","article-title":"Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement","volume":"9","author":"Treibel","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0084","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcmg.2015.04.012","article-title":"Coexistence of degenerative aortic stenosis and wild-type transthyretin-related cardiac amyloidosis","volume":"9","author":"Longhi","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0085","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Castano","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0086","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12968-017-0415-x","article-title":"Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis","volume":"19","author":"Cavalcante","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0087","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1002\/ejhf.1756","article-title":"Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome","volume":"22","author":"Nitsche","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0088","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0089","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030271","article-title":"Amyloid transthyretin cardiomyopathy in elderly patients with aortic stenosis undergoing transcatheter aortic valve implantation","volume":"12","author":"Dobner","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0090","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1002\/ehf2.14709","article-title":"Histological assessment of cardiac amyloidosis in patients undergoing transcatheter aortic valve replacement","volume":"11","author":"Beuthner","year":"2024","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0091","doi-asserted-by":"crossref","first-page":"384","DOI":"10.62347\/HJHT9161","article-title":"Prevalence of transthyretin cardiac amyloidosis in patients with aortic stenosis","volume":"14","author":"SadrAldin","year":"2024","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0092","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1002\/ehf2.15258","article-title":"Transthyretin amyloid cardiomyopathy in aortic stenosis patients scheduled for transcatheter aortic valve implantation","volume":"12","author":"Holt","year":"2025","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0093","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.amjcard.2023.04.003","article-title":"Transcatheter aortic valve implantation in cardiac amyloidosis and aortic stenosis","volume":"198","author":"Riley","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0094","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1002\/ehf2.13876","article-title":"Transcatheter aortic valve replacement in aortic stenosis and cardiac amyloidosis: a systematic review and meta-analysis","volume":"9","author":"Cannata","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jacc.2025.09.004","article-title":"Transthyretin cardiac amyloidosis evaluation and management: 2025 ACC Concise Clinical Guidance","volume":"87","author":"Kittleson","year":"2026","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0096","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehad347","article-title":"Conventional heart failure therapy in cardiac ATTR amyloidosis","volume":"44","author":"Ioannou","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0097","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.jacc.2024.03.429","article-title":"SGLT2 inhibitor therapy in patients with transthyretin amyloid cardiomyopathy","volume":"83","author":"Porcari","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0098","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/ejhf.3198","article-title":"Sodium-glucose cotransporter 2 inhibitors for transthyretin amyloid cardiomyopathy: Analyses of short-term efficacy and safety","volume":"26","author":"Lang","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0099","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jchf.2021.06.007","article-title":"Spironolactone in patients with an echocardiographic HFpEF phenotype suggestive of cardiac amyloidosis: results from TOPCAT","volume":"9","author":"Sperry","year":"2021","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0100","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0101","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/ejhf.70022","article-title":"Low-dose digoxin improves cardiac function in patients with heart failure, preserved ejection fraction and atrial fibrillation\u2014the RATE-AF randomized trial","volume":"27","author":"Bunting","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0102","doi-asserted-by":"crossref","first-page":"e1088","DOI":"10.1161\/CIR.0000000000000979","article-title":"Evaluation and management of aortic stenosis in chronic kidney disease: a scientific statement from the American Heart Association","volume":"143","author":"Shroff","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0103","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.05.099","article-title":"Contrast-induced acute kidney injury","volume":"68","author":"McCullough","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0104","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.70184","article-title":"Efficacy of SGLT2 inhibitors on clinical outcomes after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"9","author":"Daniyal","year":"2026","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/j.cardfail.2026.06.011_bib0106","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3343\/alm.2023.43.3.225","article-title":"Biomarkers in heart failure: from research to clinical practice","volume":"43","author":"Berezin","year":"2023","journal-title":"Ann Lab Med"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191642600374X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107191642600374X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:46:25Z","timestamp":1784864785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107191642600374X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":107,"alternative-id":["S107191642600374X"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.06.011","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart Failure Pharmacotherapy Across the Transcatheter Aortic Valve Replacement Continuum","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}